SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9 - Solicitation, recommendation statements:
SEC Accession No. 0001193125-20-283461
Filing Date
2020-11-02
Accepted
2020-11-02 09:12:29
Documents
4

Document Format Files

Seq Description Document Type Size
1 SC 14D9 d68209dsc14d9.htm SC 14D9 370191
2 EX-(A)(5)(B) d68209dex99a5b.htm EX-99.(A)(5)(B) 53310
3 EX-(E)(2) d68209dex99e2.htm EX-99.(E)(2) 41179
4 GRAPHIC g68209g1030204203263.jpg GRAPHIC 2408
  Complete submission text file 0001193125-20-283461.txt   469677
Mailing Address 2 RIGHTER PARKWAY, SUITE 200 WILMINGTON DE 19803
Business Address 35 WILBUR ST LYNBROOK NY 11563 302-842-8450
BIOSPECIFICS TECHNOLOGIES CORP (Filed by) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2 RIGHTER PARKWAY, SUITE 200 WILMINGTON DE 19803
Business Address 35 WILBUR ST LYNBROOK NY 11563 302-842-8450
BIOSPECIFICS TECHNOLOGIES CORP (Subject) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9 | Act: 34 | File No.: 005-79091 | Film No.: 201279144
SIC: 2834 Pharmaceutical Preparations